z-logo
open-access-imgOpen Access
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007
Author(s) -
K.D. Miller,
S.K. Althouse,
L. Nabell,
H Rugo,
LA Carey,
G. Kimmick,
D.R. Jones,
M.J. Merino,
P.S. Steeg
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/naw8-b853
Subject(s) - medroxyprogesterone acetate , breast cancer , metastatic breast cancer , medicine , medroxyprogesterone , oncology , cancer , hormone receptor , hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom